Aetna Medical Policy Updates – November 2022

Click here to view the Aetna Medical Policy Updates »

November 2022 Aetna Medical Policy Updates:

• Ablative Procedures for Prostate Cancer
• Acoustic Pharyngometers and SNAP Testing System
• Acute Ischemic Stroke Treatments
• ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP)
• Afamelanotide (Scenesse)
• Alzheimer’s Disease: Experimental Tests
• Alzheimer’s Disease: Experimental Treatments
• Androgens and Anabolic Steroids
• AngioJet Rheolytic Thrombectomy System
• Autonomic Testing / Sudomotor Tests
• Axial Lumbar Interbody Fusion (AxiaLIF)
• Balloon Valvuloplasty
• Benralizumab (Fasenra)
• Bevacizumab for Non-Ocular Indications
• Bone and Tendon Graft Substitutes and Adjuncts
• Brachial Plexus Surgery
• Cardiopulmonary Exercise Testing
• Cardioverter-Defibrillators
• Carotid Sinus Stimulation for Hypertension
• Cold Laser and High-Power Laser Therapies
• Comparative Genomic Hybridization (CGH)
• Computerized Wheeze Detectors
• Constraint-Induced Therapy
• Coronary Artery Brachytherapy and Other Adjuncts to Coronary Interventions
• Dexamethasone Ophthalmic Implants (Ozurdex and Dextenza)
• Distal Interphalangeal (DIP), Metacarpophalangeal (MCP) and Proximal Interphalangeal (PIP) Joint Implants
• Double Balloon Enteroscopy
• Eculizumab (Soliris)
• Electric Tumor Treatment Fields
• Electrical Stimulation for Nausea, Vomiting and Motion Sickness (PrimaBella and ReliefBand) and Other Selected Indications
• Electroconvulsive Therapy
• Epilepsy Surgery
• Esophageal and Airway pH Monitoring
• Esophageal Doppler Monitoring
• Exhaled Breath Tests
• Extracorporeal Membrane Oxygenation (ECMO)
• Face Transplantation
• Fam-trastuzumab Deruxtecan-nxki (Enhertu)
• Fecal Bacteriotherapy
• Fetal Surgery In Utero
• Functional Electrical Stimulation and Neuromuscular Electrical Stimulation
• Gastric Pacing / Electrical Stimulation and Gastric Per Oral Endoscopic Myotomy
• Genetic Testing
• Glaucoma Surgery
• Golimumab (Simponi and Simponi Aria)
• Golimumab (Simponi and Simponi Aria) [Medicare]
• Gonadotropin-Releasing Hormone Analogs and Antagonists
• Graves’ Ophthalmopathy Treatments
• Hand Transplantation
• Heating Devices
• Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
• Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders
• Hematopoietic Cell Transplantation for Solid Tumors in Adults
• Hematopoietic Cell Transplantation for Waldenstrom Macroglobulinemia
• Hematopoietic Colony-Stimulating Factors (CSFs)
• Hematopoietic Colony-Stimulating Factors (CSFs) [Medicare]
• High-Resolution Anoscopy
• Home Hemoglobin Testing Devices
• Hypoxic Ischemic Encephalopathy
• Implantable Left Atrial Hemodynamic Monitor
• In Vivo Analysis of Gastro-Intestinal and Urothelial Lesions
• Infertility
• Infliximab
• Infliximab [Medicare]
• Interferons
• Internal Fixation of Rib Fracture
• Interstitial Laser Therapy
• Intra-coronary Hyperoxemic Therapy
• Intraoperative Electromyographic Monitoring
• Intra-vascular Optical Coherence Tomography
• Intravenous Iron Therapy
• Ipilimumab (Yervoy)
• Irreversible Electroporation (NanoKnife)
• Levoleucovorin (Fusilev and Khapzory)
• Low-Molecular-Weight Heparins and Thrombin Inhibitors
• Lurbinectedin (Zepzelca)
• Lutetium Lu 177 Dotatate (Lutathera)
• Lymphangioma and Infantile Hemangioma
• Magnetic Resonance Imaging (MRI) of the Extremities
• Magnetic Resonance Imaging of the Cardiovascular System – Cardiac MRI
• Mammography
• Management of Meibomian Glands
• Mecasermin (Increlex)
• Menaflex
• Mepolizumab (Nucala)
• Mifepristone
• Mohs Micrographic Surgery
• Multiple Sclerosis
• Multiple Sclerosis [Medicare]
• Natalizumab (Tysabri)
• Natalizumab (Tysabri) [Medicare]
• Naxitamab-gqgk (Danyelza)
• Near-Infrared (NIR) Spectroscopy
• Nerve Conduction Studies
• Nerve Fiber Density Measurement
• Neurogenic Bladder: Selected Treatments
• Non-invasive Measurement of Advanced Glycation End-products in the Skin
• Novel Injection Methods
• Palifermin (Kepivance)
• Parkinson’s Disease
• Peripheral Atherectomy and Thrombectomy Devices
• Peripheral Vascular Stents
• Pharmacogenetic and Pharmacodynamic Testing
• Phototherapy for Psychiatric Disorders
• Polymerase Chain Reaction Testing: Selected Indications
• Positron Emission Tomography (PET)
• Premenstrual Syndrome and Premenstrual Dysphoric Disorder
• Pressure Reducing Support Surfaces
• Progestins
• Pudendal Nerve Decompression
• Radiofrequency Ablation of the Renal Sympathetic Nerve
• Radium Ra 223 Dichloride (Xofigo)
• Remote Ischemic Conditioning
• Reslizumab (Cinqair)
• Rituximab
• Rituximab [Medicare]
• Robotic-assisted Rehabilitation of the Extremities
• Selected Kidney Function Tests
• Single Photon Emission Computed Tomography (SPECT)
• Smallpox Vaccine
• Somatostatin Analogs
• Tocilizumab (Actemra)
• Tocilizumab (Actemra) [Medicare]
• Total-Body CT Screening
• Tourette’s Syndrome
• Transcatheter Aortic Valve Implantation
• Transcatheter Pulmonary Valve Implantation
• Transcranial Doppler Ultrasonography
• Transcranial Magnetic Stimulation and Cranial Electrical Stimulation
• Transplant Immune Cell Function Assays
• Transvaginal Ultrasonography
• Tumor Markers
• T-Wave Alternans
• Vaccines for Travel
• Vascular Endothelial Growth Factor Inhibitors for Ocular Indications
• Vascular Endothelial Growth Factor Inhibitors for Ocular Indications [Medicare]
• Viscosupplementation [Medicare]
• Vision Therapy
• Wheelchairs and Power Operated Vehicles (Scooters)

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.